SODIUM LACTATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Lactate, and when can generic versions of Sodium Lactate launch?
Sodium Lactate is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in five NDAs.
The generic ingredient in SODIUM LACTATE is sodium lactate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium lactate profile page.
Summary for SODIUM LACTATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM LACTATE at DailyMed |
Recent Clinical Trials for SODIUM LACTATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Maryland, Baltimore | Phase 4 |
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
Emory University | Phase 4 |